Virax Biolabs Group Limited — Cash Flow (NASDAQ:VRAX) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities -809.07 K-4.18 M-6.25 M-4.56 M — Cash from investing activities —-178.4 K-1.16 M-603.89 K — Cash from financing activities 813.2 K13.69 M1.65 M5.81 M — Free cash flow -809.07 K-4.18 M-6.25 M-4.56 M —

新闻

Virax Biolabs Group Limited (VRAX) Upgraded to Buy: Here's Why

H.C. Wainwright将Virax Biolabs股票目标价从3.00美元下调至1.00美元

Virax Biolabs stock price target lowered to $1 at H.C. Wainwright

Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Axogen (NASDAQ:AXGN), Addex Therapeutics (NASDAQ:ADXN)

Virax Biolabs (VRAX) Stock Cools After Hours Following 75% Rally - Virax Biolabs Group (NASDAQ:VRAX)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.86%

美国股市上涨；截至收盘道琼斯工业平均指数上涨0.86%

Virax Biolabs股价在后感染诊断临床进展后飙升

Virax Biolabs stock rockets after clinical progress in post-infection diagnostics

Crude Oil Gains 1%; Macy's Reports Strong Q3 Results - Aeva Technologies (NASDAQ:AEVA), ADC Therapeutics (NYSE:ADCT)

US Stocks Mixed; Dollar Tree Posts Upbeat Earnings - Black Diamond Therapeutic (NASDAQ:BDTX), Capricor Therapeutics (NASDAQ:CAPR)

Virax Biolabs partners with Emory for long COVID diagnostic studies